CAMBRIDGE, MA—King Street Properties hassecured $89 million in acquisition and repositioning financing inconnection with its purchase of two former Pfizerlaboratory buildings near the Alewife MBTA Station.

The combined purchase price for the two properties at 87Cambridge Park Drive and 200 Cambridge Park Drive is $54.5 million.HFF, working on behalf of King Street Properties,LLC, placed both acquisition/repositioning loans throughCornerstone Real Estate Advisers, which acted onbehalf of its advisory clients. A $22-million, floating-rate loanwas secured for 87 Cambridge Park Drive and a $67-million,floating-rate loan was secured for 200 Cambridge Park Drive. TheHFF team representing the borrower was led by Managing DirectorGreg LaBine.

The cost of the acquisition and repositioning of the propertiesis $112 million, according to HFF. 87 Cambridge Park Drive is a62,492-square-foot office/laboratory building that is currentlyvacant. 200 Cambridge Park Drive is a vacant six-story221,676-square-foot Class A office/laboratory facility that wasrenovated in 2004. Both properties will be renovated, repositionedand re-leased by King Street. Cushman andWakefield is handling the leasing of both properties.

Continue Reading for Free

Register and gain access to:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

John Jordan

John Jordan is a veteran journalist with 36 years of print and digital media experience.